aminochrome 1 has been researched along with dihydropyridines in 1 studies
| Studies (aminochrome 1) | Trials (aminochrome 1) | Recent Studies (post-2010) (aminochrome 1) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
|---|---|---|---|---|---|
| 76 | 0 | 31 | 5,022 | 529 | 969 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, ÁMAN; Barbosa, DB; Cardim-Pires, TR; Costa, ACS; Costa, SL; da Rocha Pita, SS; de Fátima Dias Costa, M; do Bomfim, MR; Dos Santos Junior, MC; Foguel, D; Fonseca-Fonseca, LA; Leite, FHA; Muñoz, P; Núñez-Figueredo, Y; Ochoa-Rodríguez, E; Outeiro, TF; Palhano, FL; Santos, CC; Segura-Aguilar, J; Shvachiy, L; Silva, VDA; Teles-Souza, J | 1 |
1 other study(ies) available for aminochrome 1 and dihydropyridines
| Article | Year |
|---|---|
JM-20, a Benzodiazepine-Dihydropyridine Hybrid Molecule, Inhibits the Formation of Alpha-Synuclein-Aggregated Species.
Topics: alpha-Synuclein; Benzodiazepines; Dihydropyridines; Humans; Molecular Docking Simulation; Neuroblastoma; Parkinson Disease | 2022 |